Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings ...

At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...

Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.

Would you like to be notified of the latest news and updates on the stock market?

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024. The stock had been on a strong ...